Navigating the Complexities of Clinical Trial Budgeting and Billing Compliance
Clinical trial activation involves a host of tasks, from institutional review board (IRB) tasks and consent form development to
Professional Services
Addressing Barriers to DEI in Clinical Research
Breaking down barriers to participation in clinical research has long been a challenge, affecting every aspect of the industry. As
Improving Access to Research for Diverse and Underserved Populations
Discover expert insights on enhancing research inclusivity through improved access, stakeholder relationships, and measurable strategies.
The State of Clinical Trial Activation at Sites
Study activation is a necessary part of a clinical trial but can be rather difficult to coordinate efficiently. There is
What is Coverage Analysis in Clinical Research?
Effective coverage analysis is crucial for billing compliance, helping sites avoid financial penalties and protect their study’s integrity.
Q&A: FDA Inspections of Clinical Investigators: Understanding the Process and What to Expect
In a recent webinar, Advarra experts Constance Cullity and Michele Russell-Einhorn presented FDA Inspections of Clinical Investigators: Understanding the Process
Study Startup Success for BioPharma and MedTech: Engage a Research Compliance Partner
A key element to successful study startup is identifying efficiencies to help meet critical milestones. Engaging with research compliance experts
Study Activation Survey Results: Budget Negotiation
Budget negotiations reveal hidden costs and extended timelines, underscoring the importance of efficient processes for clinical trial success.
Study Activation Survey Results: Medicare Coverage Analysis (MCA)
MCA timelines impact trial activation efficiency, with staffing shortages a key barrier. Many sites find sponsors receptive to covering MCA-related costs.
The State of Clinical Trial Activation at Sites Report
Explore Advarra’s Study Activation Report to uncover roadblocks, survey findings, and solutions to streamline clinical trial activation at sites.
Q&A Part II: Clinical Trial Feasibility: Ensuring Success for Clinical Sites
In a recent webinar, Advarra experts Wendy Tate and Cheryl Byers provided considerations for building an effective feasibility process, including
Q&A Part I: Clinical Trial Feasibility: Ensuring Success for Clinical Sites
In a recent webinar, Advarra experts Wendy Tate and Cheryl Byers provided considerations for building an effective feasibility process, including